explore
Previous article:
Medical records are filled with copy
Next article: Ultragenyx gene therapy for rare liver ailment succeeds in late
Next article: Ultragenyx gene therapy for rare liver ailment succeeds in late
focus
focus
-
ASCO: AstraZeneca's hat trick, and palliative care's spotlight
2025-09-27 09:56 -
Readout LOUD podcast: ASCO preview, a Duchenne trial failure
2025-09-27 09:54 -
Innovation in antibiotics is ailing. 'Brain drain' may kill it
2025-09-27 09:47 -
Shifting the focus from loneliness to social health
2025-09-27 09:10 -
Intellia reports positive results for its CRISPR
2025-09-27 09:09 -
With FDA staff opposed to Sarepta therapy, top official intervened
2025-09-27 08:16